Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
With the Sequence acquisition, the company is positioning itself to support customers who already use semaglutides like Ozempic and Wegovy, and to help get these drugs into the hands of the patient population they were intended for: people managing diabetes and those looking to lose weight as part of a doctor-recommended health plan
The GLP-1 receptor agonist market is growing rapidly, supported by rising obesity and diabetes prevalence, strong clinical outcomes, and increasing patient awareness
Eli Lillys dulaglutide was approved in September 2014 under the name Trulicity as a Type 2 diabetes treatment
Ozempic and similar semaglutide drugs might be associated with medical conditions such as gastroparesis (stomach paralysis), gallbladder disease, cyclic vomiting syndrome, and other serious conditions
With the option of telehealth visits, you can initiate your semaglutide treatment from the comfort of your home
US$ 23.79
US$ 22.68
US$ 25.87
US$ 29.34
US$ 21.01
US$ 27.66
US$ 25.42
